Sabby Management, LLC Red Hill Biopharma Ltd. Transaction History

Sabby Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.14 - $695.9 $1.04 Million - $5.18 Billion	7,450,400 New	7,450,400 $1.04 Million
Q3 2021 Nov 15, 2021	SELL	$4.55 - $10.36 $1.55 Million - $3.53 Million	-340,440 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$5.98 - $7.51 $1.74 Million - $2.18 Million	-290,847 Reduced 46.07%	340,440 $2.34 Million
Q1 2021 May 17, 2021	BUY	$6.98 - $11.29 $4.41 Million - $7.13 Million	631,287 New	631,287 $4.62 Million
Q1 2018 May 15, 2018	SELL	$4.96 - $6.84 $105,757 - $145,842	-21,322 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$4.58 - $10.81 $97,654 - $230,490	21,322	21,322 $110,000

40.4K

Ticker RDHL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 63,823,500
Market Cap $465M
Description
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for...

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sabby Management, LLC with notifications on news.